Albanian exec calls for health care reform

12 January 2009

A portion of the Albanian public health care system should be privatized, Genci Guga, the executive director of one of the country's  leading pharmaceuticals distributors, stated in a Daily Telegraph  "advertorial."

"In Albania, with the introduction of capitalism, the first rule  Albanians learned was to decrease the price," the Albtrade Pharma head  explained in the article. "We, as a company, have done it a completely  different way - we are directed to the quality of services. We work on  totally different principles, not at the expense of quality," Mr Guga  added.

Working in the private sector, Albtrade has built its business by  focusing on smaller markets, the Telegraph story noted. The firm was  founded by Enver Guga in 1996 as a syringe distribution company, before  branching out into other markets.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight